Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injury
抑制创伤性脑损伤后外周先天免疫的促解决表型的新机制
基本信息
- 批准号:10183562
- 负责人:
- 金额:$ 40万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAnti-Inflammatory AgentsAttenuatedAutomobile DrivingAxonBehaviorBehavioralBlood - brain barrier anatomyBone Marrow CellsCellsCerebrovascular CirculationChronicDataDemyelinationsDendritic CellsDichloromethylene DiphosphonateDisease ProgressionEnvironmentEphA4 ReceptorFRAP1 geneFunctional disorderHealthHippocampus (Brain)HistologicImmuneIn VitroInfiltrationInflammatoryInflammatory ResponseInjuryInnate Immune ResponseInterventionKnock-outKnockout MiceLabelLesionLightLiposomesMechanicsMediatingMediator of activation proteinMethodsModelingMolecularMusNatural ImmunityNatural Killer CellsNeurogliaNeurologicOutcomePathogenesisPathway interactionsPeripheralPharmacologyPhasePhenotypePhosphorylationPhysiologicalPlayProcessProteinsPublishingReceptor Protein-Tyrosine KinasesRecoveryRecovery of FunctionRegulationReporterResearchRoleSignal TransductionTestingTimeTissuesTransgenic OrganismsTraumaTraumatic Brain InjuryTraumatic Brain Injury recoveryUp-Regulationaxon growthaxon guidancebehavioral phenotypingchemokinecontrolled cortical impactcytokinecytotoxicdrug discoveryepigenomicsgenome-wideglial activationimmune activationimmunoregulationimprovedin vivoinjuredinjury recoveryinnovationmRNA Expressionmacrophagemonocytemouse modelneuroinflammationneuron lossneuroprotectionneurotoxicneurovascularneurovascular injuryneutrophilnew therapeutic targetnovelpreclinical studypreservationrepairedresponsetranscriptomics
项目摘要
ABSTRACT
Neuroinflammation has emerged as a critical component of secondary injury and disease progression following
brain trauma. Recent pre-clinical studies have shed light on the neurotoxic effects of peripheral innate immunity.
Our preliminary findings suggest this overzealous response may be mediated by EphA4/mTOR signaling which
negatively regulates the anti-inflammatory state of peripheral-derived monocyte/macrophages (PDMs). The
research objective of this application is to characterize the cellular and molecular mechanism(s) underlying
innate immunity and PDM polarization status in the regulation of tissue damage and functional recovery following
TBI. Our proposal builds upon extensive preliminary and published data demonstrating a distinct protective and
reduced pro-inflammatory response in the absence of peripheral EphA4 using chimeric mice following controlled
cortical impact (CCI) injury. Interestingly, PDMs-derived from EphA4null mice directly confer neuroprotection and
blood brain-barrier preservation in a model of monocyte depletion and replacement. Moreover, we discovered
that PDM-specific EphA4 suppresses phosphorylation of key proteins involved in the mTOR pathway, a novel
mediator of the pro-resolving state of PDMs. We hypothesize that EphA4 mediates the pro-inflammatory innate
immune response by suppressing mTOR signaling, which induces PDM infiltration, polarization and phenotypic
behaviors that drive neurovascular dysfunction following TBI. We will employ cell-specific depletions, and PDM
replacement as well as novel transgenic murine models. These approaches will include rigorous behavioral,
histological and innovative low-input genome-wide epigenomic and transcriptomic assessment of the relevance
and mechanism(s) of PDM behaviors. We will also provide a framework for retooling the neuroinflammatory
response to accelerate recovery and dampen pro-inflammatory processes after TBI.
摘要
神经炎症已经成为继发性损伤和疾病进展的关键组成部分,
脑外伤最近的临床前研究揭示了外周先天免疫的神经毒性作用。
我们的初步研究结果表明,这种过度热心的反应可能是由EphA 4/mTOR信号传导介导的,
负调节外周来源的单核细胞/巨噬细胞(PDM)的抗炎状态。的
本申请的研究目的是表征细胞和分子机制,
先天免疫和PDM极化状态在组织损伤和功能恢复的调节中的作用
创伤性脑损伤我们的建议是建立在广泛的初步和已发表的数据基础上的,这些数据表明,
使用嵌合小鼠,在不存在外周EphA 4的情况下,
皮质撞击(CCI)损伤。有趣的是,源自EphA 4缺失小鼠的PDM直接赋予神经保护作用,
在单核细胞耗竭和替代模型中的血脑屏障保存。此外,我们发现,
PDM特异性EphA 4抑制参与mTOR通路的关键蛋白的磷酸化,这是一种新的
调解人的前解决状态的PDM。我们假设EphA 4介导促炎性先天性炎症反应,
通过抑制mTOR信号传导,诱导PDM浸润、极化和表型分化,
导致脑外伤后神经血管功能障碍的行为。我们将采用细胞特异性消耗和PDM
替代以及新的转基因鼠模型。这些方法将包括严格的行为,
组织学和创新的低输入全基因组表观基因组学和转录组学评估的相关性
和PDM行为的机制。我们还将提供一个框架,
反应,以加速恢复和抑制促炎过程后TBI。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michelle Lee Theus其他文献
Michelle Lee Theus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michelle Lee Theus', 18)}}的其他基金
Divergent age-dependent peripheral innate immune response following TBI
TBI 后不同年龄依赖性外周先天免疫反应
- 批准号:
10427434 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injury
抑制创伤性脑损伤后外周先天免疫的促解决表型的新机制
- 批准号:
10814445 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injury
抑制创伤性脑损伤后外周先天免疫的促解决表型的新机制
- 批准号:
10409794 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Novel mechanisms suppressing the pro-resolving phenotype of peripheral innate immunity following traumatic brain injury
抑制创伤性脑损伤后外周先天免疫的促解决表型的新机制
- 批准号:
10607999 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Divergent age-dependent peripheral innate immune response following TBI
TBI 后不同年龄依赖性外周先天免疫反应
- 批准号:
10295232 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Divergent age-dependent peripheral innate immune response following TBI
TBI 后不同年龄依赖性外周先天免疫反应
- 批准号:
10653859 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Novel mechanisms suppressing pro-resolving innate immunity following traumatic brain injury
抑制创伤性脑损伤后先天免疫的新机制
- 批准号:
10572099 - 财政年份:2021
- 资助金额:
$ 40万 - 项目类别:
Novel Cellular and Molecular Regulation of Collateral Remodeling in Ischemic Stroke
缺血性中风侧枝重塑的新型细胞和分子调节
- 批准号:
10452552 - 财政年份:2019
- 资助金额:
$ 40万 - 项目类别:
Novel Cellular and Molecular Regulation of Collateral Remodeling in Ischemic Stroke
缺血性中风侧枝重塑的新型细胞和分子调节
- 批准号:
10197241 - 财政年份:2019
- 资助金额:
$ 40万 - 项目类别:
Novel Cellular and Molecular Regulation of Collateral Remodeling in Ischemic Stroke
缺血性中风侧枝重塑的新型细胞和分子调节
- 批准号:
10642764 - 财政年份:2019
- 资助金额:
$ 40万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 40万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 40万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 40万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 40万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 40万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 40万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 40万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 40万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 40万 - 项目类别: